Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?
Open Access
- 1 August 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 49 (8) , 1272-1275
- https://doi.org/10.1373/49.8.1272
Abstract
Writing on the future of cancer diagnostics, this author has predicted that multiparametric biomarker analysis, in combination with artificial neural networks aKeywords
This publication has 17 references indexed in Scilit:
- Re: Serum proteomic patterns for detection of prostate cancer.JNCI Journal of the National Cancer Institute, 2003
- Serum Proteomic Patterns for Detection of Prostate CancerJNCI Journal of the National Cancer Institute, 2002
- Cancer Diagnostics: Discovery and Clinical Applications—IntroductionClinical Chemistry, 2002
- Proteomic patterns in serum and identification of ovarian cancerThe Lancet, 2002
- The SELDI-TOF MS Approach to Proteomics: Protein Profiling and Biomarker IdentificationBiochemical and Biophysical Research Communications, 2002
- The ProteinChip® Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validationBiochemical Society Transactions, 2002
- Use of proteomic patterns in serum to identify ovarian cancerPublished by Elsevier ,2002
- Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesProstate Cancer and Prostatic Diseases, 1999
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the ProstateCritical Reviews in Clinical Laboratory Sciences, 1998